Seroatlas · Human Serome Atlas

ATP6V1A

V-type proton ATPase catalytic subunit A

Also known as: ATP6A1, ATP6V1A1, VA68, VATA_HUMAN, Vma1, VPP2

Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
P38606
Gene
ATP6V1A
Ensembl
ENSG00000114573
Chromosome
3
Canonical length
617 aa
Protein class
Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transporters
Subcellular location
Nucleoplasm,Vesicles,Cytosol

OverviewNCBI Gene

This gene encodes a component of vacuolar ATPase (V-ATPase), a multisubunit enzyme that mediates acidification of eukaryotic intracellular organelles. V-ATPase dependent organelle acidification is necessary for such intracellular processes as protein sorting, zymogen activation, receptor-mediated endocytosis, and synaptic vesicle proton gradient generation. V-ATPase is composed of a cytosolic V1 domain and a transmembrane V0 domain. The V1 domain consists of three A and three B subunits, two G subunits plus the C, D, E, F, and H subunits. The V1 domain contains the ATP catalytic site. The V0 domain consists of five different subunits: a, c, c', c"""""""""""""""""""""""""""""""", and d. Additional isoforms of many of the V1 and V0 subunit proteins are encoded by multiple genes or alternatively spliced transcript variants. This encoded protein is one of two V1 domain A subunit isoforms and is found in all tissues. Transcript variants derived from alternative polyadenylation exist. [provided by RefSeq, Jul 2008]

Canonical amino-acid sequenceUniProt

617 residues, UniProt reviewed canonical sequence.

>P38606|ATP6V1A
     1  MDFSKLPKIL DEDKESTFGY VHGVSGPVVT ACDMAGAAMY ELVRVGHSEL VGEIIRLEGD
    61  MATIQVYEET SGVSVGDPVL RTGKPLSVEL GPGIMGAIFD GIQRPLSDIS SQTQSIYIPR
   121  GVNVSALSRD IKWDFTPCKN LRVGSHITGG DIYGIVSENS LIKHKIMLPP RNRGTVTYIA
   181  PPGNYDTSDV VLELEFEGVK EKFTMVQVWP VRQVRPVTEK LPANHPLLTG QRVLDALFPC
   241  VQGGTTAIPG AFGCGKTVIS QSLSKYSNSD VIIYVGCGER GNEMSEVLRD FPELTMEVDG
   301  KVESIMKRTA LVANTSNMPV AAREASIYTG ITLSEYFRDM GYHVSMMADS TSRWAEALRE
   361  ISGRLAEMPA DSGYPAYLGA RLASFYERAG RVKCLGNPER EGSVSIVGAV SPPGGDFSDP
   421  VTSATLGIVQ VFWGLDKKLA QRKHFPSVNW LISYSKYMRA LDEYYDKHFT EFVPLRTKAK
   481  EILQEEEDLA EIVQLVGKAS LAETDKITLE VAKLIKDDFL QQNGYTPYDR FCPFYKTVGM
   541  LSNMIAFYDM ARRAVETTAQ SDNKITWSII REHMGDILYK LSSMKFKDPL KDGEAKIKSD
   601  YAQLLEDMQN AFRSLED

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against ATP6V1A can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Intracellular
Secreted
No
Transmembrane segments
0
Mean surface accessibility (rSASA)
0.23
Highest tissue expression
87 nTPM

Expression across tissuesHPA

Tissue

  • kidney: 87 nTPM
  • cerebral cortex: 86 nTPM
  • parathyroid gland: 56 nTPM
  • retina: 55 nTPM
  • hypothalamus: 52 nTPM
  • choroid plexus: 51 nTPM

Single-cell type

  • late spermatids: 1,352 nCPM
  • early spermatids: 759 nCPM
  • neutrophils: 680 nCPM
  • respiratory ionocytes: 612 nCPM
  • epididymal clear cells: 517 nCPM
  • salivary ionocytes: 488 nCPM

Immune cell

  • neutrophil: 79 nTPM
  • myeloid DC: 36 nTPM
  • classical monocyte: 35 nTPM
  • basophil: 30 nTPM
  • intermediate monocyte: 26 nTPM
  • non-classical monocyte: 23 nTPM

Brain region

  • choroid plexus: 198 nTPM
  • hypothalamus: 180 nTPM
  • cerebral cortex: 180 nTPM
  • basal ganglia: 159 nTPM
  • pons: 153 nTPM
  • hippocampal formation: 143 nTPM

DiseaseUniProt · ClinVar · IEDB · PubMed

Four sources answering four different questions about ATP6V1A.

Disease | AllUniProt

Conditions ATP6V1A is implicated in, by any mechanism.

Disease | GeneticClinVar

26 pathogenic / likely-pathogenic of 455 ClinVar records.

Conditions with pathogenic or likely-pathogenic variants.

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD LOEUF (loss-of-function intolerance)
0.36
gnomAD pLI
0.87
gnomAD missense Z
3.37
DepMap mean gene effect
-1.91
DepMap dependency class
pan

Cancer expressionTCGA

Across TCGA tumor cohorts, this protein is over-expressed in roughly 8% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).

OntologyGO

Biological processes

Molecular functions

Cellular components

Protein domainsUniProt · Pfam · InterPro

KeywordsUniProt

InteractionsUniProt · HPA

Protein binding partners of ATP6V1A in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads ATP6V1A as an antibody target. Whether an autoantibody or antibody against ATP6V1A could matter depends on whether native ATP6V1A is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

ATP6V1A is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.

Annotation status

The present source text does not explicitly label ATP6V1A as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Canonical record: https://seroatlas.com/gene/ATP6V1A. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...